We are live on ! Find out more
PRVA icon

Privia Health

226 hedge funds and large institutions have $2.72B invested in Privia Health in 2023 Q4 according to their latest regulatory filings, with 31 funds opening new positions, 96 increasing their positions, 72 reducing their positions, and 19 closing their positions.

New
Increased
Maintained
Reduced
Closed

807% more call options, than puts

Call options by funds: $4.84M | Put options by funds: $534K

63% more first-time investments, than exits

New positions opened: 31 | Existing positions closed: 19

33% more repeat investments, than reductions

Existing positions increased: 96 | Existing positions reduced: 72

7% more capital invested

Capital invested by funds: $2.55B → $2.72B (+$169M)

5.5% more ownership

Funds ownership: 94.62%100.12% (+5.5%)

4% more funds holding

Funds holding: 218226 (+8)

0% more funds holding in top 10

Funds holding in top 10: 11 (0)

Holders
226
Holders Change
+8
Holders Change %
+3.67%
% of All Funds
3.29%
Holding in Top 10
1
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
0.01%
New
31
Increased
96
Reduced
72
Closed
19
Calls
$4.84M
Puts
$534K
Net Calls
+$4.31M
Net Calls Change
-$137K
Name Holding Trade Value Shares
Change
Change in
Stake
BlackRock
1
BlackRock
New York
$394M +$15.6M +697,778 +4%
Fidelity Investments
2
Fidelity Investments
Massachusetts
$365M +$35.2M +1,574,205 +11%
Vanguard Group
3
Vanguard Group
Pennsylvania
$260M +$6.14M +274,345 +2%
DCP
4
Durable Capital Partners
Maryland
$209M
RF
5
Rubicon Founders
Tennessee
$120M +$117M +5,211,136 New
T. Rowe Price Investment Management
6
T. Rowe Price Investment Management
Maryland
$109M -$130K -5,819 -0.1%
RP
7
Riverbridge Partners
Minnesota
$106M +$7.8M +348,328 +8%
Wellington Management Group
8
Wellington Management Group
Massachusetts
$100M -$7.02M -313,613 -7%
State Street
9
State Street
Massachusetts
$90.8M +$10.7M +476,943 +14%
Bank of New York Mellon
10
Bank of New York Mellon
New York
$86M -$6.85M -306,183 -8%
Principal Financial Group
11
Principal Financial Group
Iowa
$80.8M +$69.3K +3,097 +0.1%
Geode Capital Management
12
Geode Capital Management
Massachusetts
$54.5M +$3.11M +138,946 +6%
Morgan Stanley
13
Morgan Stanley
New York
$47.6M +$32M +1,431,102 +225%
Invesco
14
Invesco
Georgia
$42.1M +$2.3M +102,934 +6%
Northern Trust
15
Northern Trust
Illinois
$31.2M +$229K +10,221 +0.8%
Franklin Resources
16
Franklin Resources
California
$31.2M +$33.7K +1,504 +0.1%
APM
17
Avidity Partners Management
Texas
$29.6M -$5.78M -258,100 -17%
Norges Bank
18
Norges Bank
Norway
$28M +$5.56M +248,628 +26%
BG
19
Bellevue Group
Switzerland
$24.2M -$77.9K -3,482 -0.3%
SIG
20
Senator Investment Group
New York
$23M -$224K -10,000 -1%
EAM
21
Eventide Asset Management
Massachusetts
$23M
EA
22
Emerald Advisers
Pennsylvania
$22.7M +$1.67M +74,648 +8%
Charles Schwab
23
Charles Schwab
California
$19.6M +$668K +29,835 +4%
Loomis, Sayles & Company
24
Loomis, Sayles & Company
Massachusetts
$19.3M +$4.75M +212,453 +34%
EMFAT
25
Emerald Mutual Fund Advisers Trust
Pennsylvania
$18.7M +$1.57M +70,224 +9%

PRVA Hedge Fund Activity: Q4 2023 in Review

226 of the 6,859 institutional investors tracked by Wall St. Rank reported a position in Privia Health (PRVA) for Q4 2023, worth a combined $2.72B — up 6.6% from $2.55B a quarter earlier.

Buyers outnumbered sellers: 31 funds opened new PRVA positions and 19 closed out — a net gain of 12 holders — while 96 added to existing stakes and 72 trimmed.

The largest buyer was Fidelity Investments, adding an estimated $35.2M. The largest seller was Janus Henderson Group, cutting an estimated $19M.

  • 226 institutional investors held Privia Health (PRVA) as of Q4 2023, up from 218 in Q3 2023.
  • Funds reported $2.72B of Privia Health stock for Q4 2023, up 6.6% quarter-over-quarter.
  • 31 funds opened new Privia Health positions in Q4 2023 and 19 closed out, a net change of +12 holders.
  • The largest Privia Health buyer in Q4 2023 was Fidelity Investments, an estimated $35.2M added.
  • The largest Privia Health seller in Q4 2023 was Janus Henderson Group, an estimated $19M sold.

Based on aggregated 13F filings for Q4 2023.